Eagle Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-802,253
| Closed | -$29.1M | – | 529 |
|
|
2024
Q2 | $29.1M | Sell |
802,253
-43,280
| -5% | -$1.57M | 0.16% | 145 |
|
|
2024
Q1 | $50.5M | Buy |
845,533
+399,533
| +90% | +$23.9M | 0.26% | 132 |
|
|
2023
Q4 | $26.7M | Sell |
446,000
-3,970
| -0.9% | -$238K | 0.14% | 159 |
|
|
2023
Q3 | $17.1M | Sell |
449,970
-962
| -0.2% | -$36.6K | 0.1% | 193 |
|
|
2023
Q2 | $41.1M | Buy |
450,932
+221,550
| +97% | +$20.2M | 0.23% | 133 |
|
|
2023
Q1 | $15.1M | Buy |
229,382
+93,268
| +69% | +$6.15M | 0.09% | 194 |
|
|
2022
Q4 | $6.84M | Sell |
136,114
-5,103
| -4% | -$257K | 0.04% | 289 |
|
|
2022
Q3 | $9.65M | Buy |
+141,217
| New | +$9.65M | 0.06% | 244 |
|